down arrow

Alembic Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE901L01018
  • NSEID: APLLTD
  • BSEID: 533573
INR
840.00
1.5 (0.18%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 87.77 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

840.00864.45

52 Week

725.601,296.15
Valuation
Technical
Day's Volume

CASH

87.77 k (9.48%) Volume

Shareholding (Dec 2024)

FII

4.17%

Held by 164 FIIs

DII

16.06%

Held by 23 DIIs

Promoter

69.61%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate -5.07% of over the last 5 years

 
2

Negative results in Dec 24

3

Stock is technically in a Bearish range

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 16,511 Cr (Mid Cap)

stock-summary
P/E

28.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

1.31%

stock-summary
Debt Equity

0.19

stock-summary
Return on Equity

13.01%

stock-summary
Price to Book

3.37

Revenue and Profits (1 Year):
Net Sales:
1,693 Cr
(Quarterly Results - Dec 2024)
Net Profit:
138 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.31%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-28.02%
0%
-28.02%
1 Year
-15.39%
1.11%
-14.28%
2 Years
64.98%
3.20%
68.18%
3 Years
8.25%
4.00%
12.25%
4 Years
-16.89%
4.56%
-12.33%
5 Years
26.52%
4.79%
31.31%

Latest dividend: 11 per share ex-dividend date: Jul-15-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
8.21%
EBIT Growth (5y)
-5.07%
EBIT to Interest (avg)
30.79
Debt to EBITDA (avg)
0.85
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.00
Tax Ratio
13.54%
Dividend Payout Ratio
35.11%
Pledged Shares
0
Institutional Holding
20.23%
ROCE (avg)
15.20%
ROE (avg)
14.23%
Valuation key factors
Factor
Value
P/E Ratio
28
Industry P/E
33
Price to Book Value
3.37
EV to EBIT
24.28
EV to EBITDA
17.48
EV to Capital Employed
2.99
EV to Sales
2.71
PEG Ratio
27.76
Dividend Yield
1.31%
ROCE (Latest)
12.43%
ROE (Latest)
13.01%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 21 Schemes (8.96%)

FIIs

Held by 164 FIIs (4.17%)

Promoter with highest holding

Nirayu Limited (35.63%)

Highest Public shareholder

Dsp Midcap Fund (4.38%)

Individual Investors Holdings

7.26%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 3.81% vs 8.05% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -23.29% vs 48.01% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,692.74",
          "val2": "1,630.57",
          "chgp": "3.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "260.22",
          "val2": "266.37",
          "chgp": "-2.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "22.26",
          "val2": "15.17",
          "chgp": "46.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "138.42",
          "val2": "180.45",
          "chgp": "-23.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.37%",
          "val2": "16.34%",
          "chgp": "-0.97%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 4.17% vs 12.57% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 12.04% vs 281.15% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,209.71",
          "val2": "3,081.08",
          "chgp": "4.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "476.09",
          "val2": "406.94",
          "chgp": "16.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "31.99",
          "val2": "30.08",
          "chgp": "6.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "12.87",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "288.12",
          "val2": "257.16",
          "chgp": "12.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.83%",
          "val2": "13.21%",
          "chgp": "1.62%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 4.05% vs 10.96% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -2.53% vs 131.06% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,902.45",
          "val2": "4,711.65",
          "chgp": "4.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "736.31",
          "val2": "673.31",
          "chgp": "9.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "54.25",
          "val2": "45.25",
          "chgp": "19.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "12.87",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "426.54",
          "val2": "437.61",
          "chgp": "-2.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.02%",
          "val2": "14.29%",
          "chgp": "0.73%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 10.19% vs 6.54% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 80.07% vs -37.33% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,228.63",
          "val2": "5,652.62",
          "chgp": "10.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "933.36",
          "val2": "708.37",
          "chgp": "31.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "56.19",
          "val2": "50.17",
          "chgp": "12.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "615.82",
          "val2": "341.99",
          "chgp": "80.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.98%",
          "val2": "12.53%",
          "chgp": "2.45%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,692.74
1,630.57
3.81%
Operating Profit (PBDIT) excl Other Income
260.22
266.37
-2.31%
Interest
22.26
15.17
46.74%
Exceptional Items
0.00
0.00
Consolidate Net Profit
138.42
180.45
-23.29%
Operating Profit Margin (Excl OI)
15.37%
16.34%
-0.97%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 3.81% vs 8.05% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is -23.29% vs 48.01% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
3,209.71
3,081.08
4.17%
Operating Profit (PBDIT) excl Other Income
476.09
406.94
16.99%
Interest
31.99
30.08
6.35%
Exceptional Items
12.87
0.00
Consolidate Net Profit
288.12
257.16
12.04%
Operating Profit Margin (Excl OI)
14.83%
13.21%
1.62%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 4.17% vs 12.57% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 12.04% vs 281.15% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
4,902.45
4,711.65
4.05%
Operating Profit (PBDIT) excl Other Income
736.31
673.31
9.36%
Interest
54.25
45.25
19.89%
Exceptional Items
12.87
0.00
Consolidate Net Profit
426.54
437.61
-2.53%
Operating Profit Margin (Excl OI)
15.02%
14.29%
0.73%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 4.05% vs 10.96% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -2.53% vs 131.06% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
6,228.63
5,652.62
10.19%
Operating Profit (PBDIT) excl Other Income
933.36
708.37
31.76%
Interest
56.19
50.17
12.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
615.82
341.99
80.07%
Operating Profit Margin (Excl OI)
14.98%
12.53%
2.45%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 10.19% vs 6.54% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 80.07% vs -37.33% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Alembic Pharmaceuticals Ltd. stock-summary
stock-summary
Alembic Pharmaceuticals Ltd.
Mid Cap
Pharmaceuticals & Drugs
Alembic Pharmaceuticals manufactures and markets generic pharmaceutical products all over the world. The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in branded generics in India. Alembic Pharmaceuticals Ltd was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Ltd. The company is engaged in pharmaceuticals business.
Company Coordinates stock-summary
Company Details
Alembic Road , Vadodara Gujarat : 390003
stock-summary
Tel: 91-0265-2280550
stock-summary
http://www.alembicpharmaceuticals.com
stock-summary
apl.investors@alembic.co.in
Registrar Details
Link Intime India Pvt Ltd., B-102 & B103, Shangrila Complex, First Floor, Opp: HDFC Bank, Near Radhakrishna Char Rasta, Akota, Vadodara
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."